Categories

EVP for Emerging Products Patrick Burke notes that our research and development model requires us to rely on collaborations with academics…

Continue Reading

Dr. Johnathan Lancaster talks about Myriad’s policies on patient privacy and access to their personal genetic test results. “Myriad believes that…

Continue Reading

CEO Mark Capone talks about Myriad’s 25-year history and our pioneering work in the molecular diagnostics industry, as well as his…

Continue Reading

Six years ago, my doctor told me I had prostate cancer, and the news literally brought me to my knees. To…

Continue Reading

Our EVP of Human Resources Jayne Hart talks about why Myriad is such a special and unique place to work and…

Continue Reading

VP of Medical Services Susan Manley explains what genetic mutations are and how testing can definitively determine whether or not a…

Continue Reading

Dr. Johnathan Lancaster describes advances in the field of testing for hereditary endometrial and colon cancers, which are some of the…

Continue Reading

VP of Medical Services Susan Manley talks about the emphasis Myriad places on test accuracy and the steps we take to…

Continue Reading


CEO Mark Capone talks about the primary challenges facing the molecular diagnostics industry and Myriad’s role as an industry leader in…

Continue Reading